Tuberculosis Demonstration, Research, Public and Professional Education
To assist States, political subdivisions of States, and other public and nonprofit private entities in conducting research into prevention and control of tuberculosis (TB) nationally and internationally. To conduct demonstration projects, provide TB and latent TB infections (LTBI) communication, education, training, medical consultation activities to TB programs, private providers, and other partners for the prevention and control of TB.
General information about this opportunity
Last Known Status
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Fiscal Year 2016
Support will continue as provided in fiscal year 2015. Objectives have been met. Funding was awarded to administer and promote programs for prevention, control, and elimination of tuberculosis (TB) to include the following: improve the quality, efficiency and effectiveness of tuberculosis prevention and control programs; provide technical assistance and conduct training programs to National TB Control Programs, non-governmental organizations, and other interested partners to strengthen TB treatment and control efforts worldwide and to assist domestic organizations in maintaining effective communication capacity among the nation's TB control officials and TB nursing professionals.Fiscal Year 2017
Objectives have been met. Funding was awarded to administer and promote programs for prevention, control, and elimination of tuberculosis (TB) to include the following: improve the quality, efficiency and effectiveness of tuberculosis prevention and control programs; provide technical assistance and conduct training programs to National TB Control Programs, non-governmental organizations, and other interested partners to strengthen TB treatment and control efforts worldwide.Fiscal Year 2018
Assistance was provided to four regionally-assigned Tuberculosis Centers of Excellence (TB COE) to facilitate efforts to prevent, treat, and control TB disease and latent TB infection (LTBI) in the United States (U.S.). It is estimated that support will continue as provided in fiscal year 2017.Fiscal Year 2019
It is estimated that support will continue as provided in fiscal year 2018.
This program is authorized under Sections 317(k)(2) and 317E of the Public Health Service Act (42 U.S.C. Sections 247b-6), as amended.
Who is eligible to apply/benefit from this assistance?
States, political subdivisions of States, and other public and nonprofit private entities.
States, political subdivisions of States, other public and nonprofit private entities, serving persons with TB infection and disease.
Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe the evaluation procedures, and provide a budget with justification of funds requested. For nonprofit recipients, costs will be determined in accordance with DHHS Regulations 45 CFR Part 74 Subpart Q.
What is the process for applying and being award this assistance?
Preapplication coordination is not applicable.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants must download application forms from www.Grants.gov. Applications must be submitted electronically at www.Grants.gov. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms on-line, they may contact the CDC Office of Grants Services Technical Information Management Section (OGSTIMS) staff. For this, or further assistance, contact OGSTIMS: Telephone (770) 488-2700, Email: OGSTIMS@cdc.gov. This program is subject to the requirements described in 45 CFR 92. In addition, some funding opportunities may require application form PHS 398 (OMB number 0925-0001 rev. 5/2001). Forms and instructions are available in an interactive format on the CDC web site, at the following Internet address: www.cdc.gov/od/pgo/forminfo.htm.
After officials review and approve applications, a notice of award (NoA) is prepared and processed, and appropriate notification is made to the public. Initial award provides funds for the first budget period (12 months) and NoA indicates support provided in the initial award and the recommended funding amounts for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any.
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 90 to 120 days.
From 120 to 180 days.
From 60 to 90 days. Project periods are for 3 to 5 years with 12-month budget periods. Applications must be obtained from Grants Management Officer, Office Grants Services, Centers for Disease Control and Prevention.
How are proposals selected?
All applications will be reviewed initially for completeness by CDC. Incomplete applications that do not meet the eligibility criteria will not advance. Applicants will be notified that their applications did not meet eligibility or published submission requirements. A review panel will evaluate complete, eligible applications in accordance with the "Criteria" section of the notice of funding opportunity (NOFO).
How may assistance be used?
Requests for direct assistance (i.e., "in lieu of cash") for personnel, equipment, and supplies directly related to project activities, particularly directly observed therapy, patient outreach, and program assessment will be considered. Project funds may not be used to supplant State or local funds available for tuberculosis control or to support construction costs or inpatient care.
What are the requirements after being awarded this opportunity?
See notice of funding opportunity (NOFO) for details. Awardees will meet the annual requirement to report on performance measures with the submission of an Annual Performance Report. However, CDC may request an additional report, the Performance Measure Report, in certain instances such as a jurisdiction’s response to a large TB outbreak..
In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Financial records, supporting documents, statistical records, and all other records pertinent to an award shall be retained for a period of 3 years from the date of submission of the final expenditure report or, for awards that are renewed quarterly or annually, from the date of the submission of the quarterly or annual financial report. If any litigation, claim, financial management review, or audit is started before the expiration of the 3-year period, the records shall be retained until all litigation, claims or audit findings involving the records have been resolved and final action taken. Property records must be retained in accordance with 45 CFR 74.53 and HHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
From three to five years. Budget Period: For 12 months. Method of awarding/releasing assistance: Lump.
Who do I contact about this opportunity?
Regional or Local Office
Division of Tuberculosis Elimination
1600 Clifton Road, MS E-10
Atlanta, GA 30333 US
1600 Clifton Road, MS E-07
Atlanta, GA 30333 USA
(Cooperative Agreements) FY 18$5,388,040.00; FY 19 est $5,388,040.00; FY 20 est $0.00; FY 17$5,303,518.00; FY 16$5,713,667.00; - (Cooperative Agreements) FY 18$74,880,860.00; FY 19 est $74,880,860.00; FY 20 est $0.00; -
Range and Average of Financial Assistance
$100,000 to $1,000,000 with an average of $120,000.
Regulations, Guidelines and Literature
Regulations governing this program are published under 42 CFR 51b. Guidelines are available in the application kit. PHS Grants Policy Statement No. 94-50,000 (Revised) April 1, 1994.
Examples of Funded Projects